Using acupuncture to treat XXXX .

@entity1 @entity390 @entity905 @entity913 @entity5026 @entity344 @entity7828 @entity2704 @entity148 @entity1410 @entity916 @entity3010 @entity10 @entity22
More than 60% of the @entity1 in both groups suffered from @entity3010 ( @entity3010 ) symptoms, such as @entity148 , @entity5026 , @entity22 , @entity390 and @entity344 , whereas a smaller number of @entity1 suffered from @entity913 , @entity10 and @entity2704 . There were three @entity1 from the first group and seven @entity1 from the second group who continued the medication treatment with @entity7828 , whereas one @entity1 from the first group and nine @entity1 from the second group continued to take @entity905 . In the first group, nine @entity1 stopped having @entity3010 symptoms after two AP treatments, eight @entity1 stopped having them after three treatments and one @entity1 stopped having them after four treatments. In four @entity1 from the first group and 16 @entity1 from the second group, @entity3010 symptoms appeared during the following period (cycle) or continued even after four treatments, so the medication was continued. In the first group, one @entity1 had a smaller subcutaneous @entity1410 after the AP acupoint @entity916 6. There was a statistical and relevant reduction in @entity3010 symptoms with the AP treatments in the first group (P<0.001), whereas their reduction was irrelevant in the placebo AP group (P>0.05). The success rate of AP in treating @entity3010 symptoms was 77.8%, whereas it was 5.9%. in the placebo group. The positive influence of AP in treating @entity3010 symptoms can be ascribed to its effects on the serotoninergic and opioidergic neurotransmission that modulates various psychosomatic functions. The initial positive results of @entity3010 symptoms with a holistic approach are encouraging and AP should be suggested to the @entity1 as a method of treatment.
